Infectious diseases are an increasingly formidable public health problem throughout the world. Developed nations face the rapid emergence of resistant pathogens. Innovative therapies, while highly valuable, are often reserved for the last line of defense. Other regions may lack the funds or infrastructure to provide reliable access to life-saving diagnostics and treatments. Health Advances is sensitive to balancing the requirements of different markets with the challenges of developing new products.
View our Infectious Diseases case examples.